Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAMIVUDINE for Hepatitis d: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where LAMIVUDINE was used for Hepatitis d.

Most Reported Side Effects for LAMIVUDINE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 1,905 11.4% 254 229
Virologic failure 1,894 11.4% 52 80
Drug resistance 1,889 11.3% 73 220
Pathogen resistance 1,733 10.4% 26 72
Viral mutation identified 1,631 9.8% 19 51
Treatment failure 933 5.6% 97 31
Exposure during pregnancy 846 5.1% 84 91
Drug interaction 744 4.5% 174 150
Drug ineffective 726 4.4% 172 106
Immune reconstitution inflammatory syndrome 625 3.8% 88 279
Depression 594 3.6% 154 107
Treatment noncompliance 574 3.4% 30 121
Renal impairment 535 3.2% 24 117
Pyrexia 521 3.1% 132 288
Hepatitis b 480 2.9% 164 61

Other Indications for LAMIVUDINE

Hiv infection (8,963) Product used for unknown indication (2,317) Hepatitis b (1,057) Chronic hepatitis b (998) Antiretroviral therapy (848) Acquired immunodeficiency syndrome (364) Prophylaxis against hiv infection (319) Antiviral prophylaxis (299) Prophylaxis (131) Hiv test positive (97)

Other Drugs Used for Hepatitis d

BULEVIRTIDE (42) PEGINTERFERON ALFA-2A (37) TENOFOVIR DISOPROXIL (24) TENOFOVIR ALAFENAMIDE (11) ENTECAVIR (5) PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B (5) TENOFOVIR (5)

Related Pages

LAMIVUDINE Full Profile All Hepatitis d Drugs LAMIVUDINE Demographics LAMIVUDINE Timeline